Worcester Foundation for Experimental Biology

Patent Applications and Registrations

Patent applications and USPTO patent grants for Worcester Foundation for Experimental Biology.The latest application filed is for "hybrid oligonucleotide phosphorothioates".

Company Profile

0.12.2

Worcester Foundation for Experimental Biology -
Worcester Foundation for Experimental Biology - Shrewsbury MA
Worcester Foundation for Experimental Biology - Worcester MA
Worcester Foundation for Experimental Biology - MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Hybrid oligonucleotide phosphorothioates App 20030148980 - Metelev, Valeri ; et al.	2003-08-07
Hybrid oligonucleotide phosphorothioates App 20020099192 - Metelev, Valeri ; et al.	2002-07-25
Cell-targeted lytic pore-forming agents Grant 5,824,776 - Bayley , et al. October 20, 1	1998-10-20
Cell-targeted lytic pore-forming agents Grant 5,817,771 - Bayley , et al. October 6, 1	1998-10-06
Triggered pore-forming agents Grant 5,777,078 - Bayley , et al. July 7, 1	1998-07-07
Hybrid oligonucleotide phosphorothioates Grant 5,652,355 - Metelev , et al. July 29, 1	1997-07-29
Enhancement of ribozyme catalytic activity by a neighboring facilitator oligonucleotide Grant 5,612,469 - Goodchild March 18, 1	1997-03-18
Method of site-specific alteration of RNA and production of encoded polypeptides Grant 5,366,878 - Pederson , et al. November 22, 1	1994-11-22
Method of site-specific alteration of RNA and production of encoded polypeptides Grant 5,220,007 - Pederson , et al. June 15, 1	1993-06-15
Inhibition of influenza virus replication by oligonucleotide phosphorothioates Grant 5,194,428 - Agrawal , et al. March 16, 1	1993-03-16
Method of site-specific alteration of RNA and production of encoded polypeptides Grant 5,149,797 - Pederson , et al. September 22, 1	1992-09-22
Process for synthesizing oligonucleotides and their analogs adaptable to large scale syntheses Grant 5,149,798 - Agrawal , et al. September 22, 1	1992-09-22
Diadenosine 5', 5'"-p.sup.1, p.sup.4,-tetraphosphate analogs as antithrombotic agents Grant 5,049,550 - Zamecnik September 17, 1	1991-09-17
Inhibition of HTLV-III by exogenous oligonucleotides Grant 4,806,463 - Goodchild , et al. February 21, 1	1989-02-21

Company Registrations

NCAGE Code	4B989	WORCESTER FOUNDATION!FOR EXPERIMENTAL BIOLOGY
CAGE Code	4B989	WORCESTER FOUNDATION FOR EXPERIMENTAL BIOLOGY

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.